As transcriptional factor six2 could define and regulate a multipotent self‐renewing nephron progenitor population throughout mammalian kidney development,8 we believe that six2 plays important roles in tumour progression, especially in NSCLC which displays high morbidity and mortality. This evidence concerns the gene SIX2 and non-small cell lung carcinoma.